Background: Fluoroquinolones are often used interchangeably in dogs and cats. Hypothesis: Predicted therapeutic efficacy differs among fluoroquinolones. Animals: Bacterial pathogens isolated from dogs and cats. Methods: Using microtube-dilution procedures, percent resistance and 2...
Author(s)
Boothe, D. M.; Boeckh, A.; Simpson, R. B.; Dubose, K.
Publisher
American College of Veterinary Internal Medicine, Lakewood, USA
Citation
Journal of Veterinary Internal Medicine, 2006, 20, 6, pp 1297-1306
In this study, 908 bacterial pathogens from defined infections of dogs and cats were tested for their susceptibility to the novel fluoroquinolone pradofloxacin, which was approved in 2011 for use in cats and dogs. Most of the bacteria tested (Staphylococcus aureus, Staphylococcus pseudintermedius, ...
Author(s)
Schink, A. K.; Kadlec, K.; Hauschild, T.; Michael, G. B.; Dörner, J. C.; Ludwig, C.; Werckenthin, C.; Hehnen, H. R.; Stephan, B.; Schwarz, S.
Publisher
Elsevier Ltd, Oxford, UK
Citation
Veterinary Microbiology, 2013, 162, 1, pp 119-126
Objectives: To compare the intrinsic activity of pradofloxacin, a new fluoroquinolone developed for use in veterinary medicine, with other fluoroquinolones, against anaerobic bacteria isolated from dogs and cats. Methods: One hundred and forty-one anaerobes were isolated from dogs and cats and...
Author(s)
Silley, P.; Stephan, B.; Greife, H. A.; Pridmore, A.
Publisher
Oxford University Press, Oxford, UK
Citation
Journal of Antimicrobial Chemotherapy, 2007, 60, 5, pp 999-1003
Forty-nine (49) isolates of P. multocida were obtained from throat swabs of 120 cats of various breeds, ages and from both sexes exhibiting clinical signs of upper respiratory disease in Italy [date not given]. Marbofloxacin (Vetoquinol), enrofloxacin (Bayer Italia), difloxacin (Fort Dodge Animal...
Author(s)
Fera, M. T.; Losi, E.; Pennisi, M. G.; Masucci, M.; Giannone, M.; Maugeri, T. L.; Carbone, M.
Publisher
British Veterinary Association, London, UK
Citation
Veterinary Record, 2002, 151, 6, pp 180-181
The minimum inhibitory concentration (MIC) and postantibiotic effect (PAE) of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin were evaluated in vitro against 43 feline-source Bordetella bronchiseptica strains. All strains tested were susceptible to marbofloxacin and enrofloxacin (MIC90...
Author(s)
Carbone, M.; Pennisi, M. G.; Masucci, M.; Sarro, A. de; Giannone, M.; Fera, M. T.
Publisher
Elsevier Science B.V., Amsterdam, Netherlands
Citation
Veterinary Microbiology, 2001, 81, 1, pp 79-84
Pradofloxacin (PRA) is an 8-cyano-fluoroquinolone (FQ) being developed to treat bacterial infections in dogs and cats. Its mutant prevention concentrations (MPC) were determined for Escherichia coli ATCC 8739 at 0.225 µg/ml, and for Staphylococcus aureus ATCC 6538 at 0.55 µg/ml. At drug...
Author(s)
Wetzstein, H. G.
Publisher
American Society for Microbiology (ASM), Washington, USA
Citation
Antimicrobial Agents and Chemotherapy, 2005, 49, 10, pp 4166-4173
Results are given from in vitro studies of enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin against the following pathogens in cats and dogs: staphylococci (n=241), E. coli (149), salmonella (10), Pasteurella (10), and against E. coli in pigs (207) and cattle (158) and Pasteurella in pigs...
Citation
Tierärztliche Umschau, 2000, 55, 7, pp 389-390,393-397
Author(s)
Taboada, J.; Papich, M. G.
Publisher
Eastern States Veterinary Association, Gainesville, USA
Citation
Small animal and exotics. Proceedings of the North American Veterinary Conference, Volume 19, Orlando, Florida, USA, 8-12 January, 2005, 2005, pp 854-856
Publisher
Eastern States Veterinary Association, Gainesville, USA
Citation
Small animal and exotics. Proceedings of the North American Veterinary Conference, Volume 19, Orlando, Florida, USA, 8-12 January, 2005, 2005, pp 869-870
Citation
Australian Veterinary Journal, 2000, 78, 2, pp 84-90